Artículos relacionados
[Translated article] Immunotherapy and Targeted Therapy in Patients With Advanced Melanoma and the V600 BRAF Mutation: Which One First?
enero 15, 2024
Área salud, Actas Dermo-Sifiliográficas, Elsevier España, Medicina, Vol. 115. Núm. 1. (Enero 2024)
Systemic treatment with immunotherapy or targeted therapy can significantly improve survival in patients with advanced (metastatic or high-risk) melanoma. Fifty percent of patients with melanoma have a BRAF mutation. Decisions on optimal sequencing of systemic […]
Un antipsicótico muestra actividad en un modelo de melanoma metastásico
Los hallazgos abren una nueva vía para tratar las metástasis cerebrales, al tiempo que identifican una potencial diana terapéutica.
[Translated article] Modern Concepts in Melanocytic Tumors
septiembre 26, 2023
Área salud, Actas Dermo-Sifiliográficas, Elsevier España, Medicina, Vol. 114. Núm. 5. (Mayo 2023)
The advent of molecular pathology has fueled unprecedented advances in the diagnosis and understanding of melanocytic tumors. These advances, however, have also generated concepts that may be difficult to grasp for clinical practitioners, who are […]